Grupo para la caracterización molecular de las neoplasias hematológicas
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublications in collaboration with researchers from Fondazione IRCCS Istituto Nazionale dei Tumori (4)
2020
2018
-
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study
Haematologica, Vol. 103, Núm. 7, pp. 1209-1217
2014
-
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
Nature Genetics, Vol. 46, Núm. 2, pp. 107-115
2013
-
Age and organ damage correlate with poor survival in myeloma patients: Meta-analysis of 1435 individual patient data from 4 randomized trials
Haematologica, Vol. 98, Núm. 6, pp. 980-987